Trial NCT01015443

View at ClinicalTrials.gov 
Org. Study IDs: EMR63325-012

Last trial update was posted on 2016-10-26

MeSH Interventions

Cyclophosphamide

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-Small Cell Lung Cancer

Stopping Reasons

The study is terminated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC.

Limitations And Caveats

The study is terminated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID